Capricor Therapeutics, Inc. (CAPR) In the News https://www.capricor.com/investors/news-events/in-the-news/rss en-us https://d1io3yog0oux5.cloudfront.net/capricor/files/theme/images/logo-sm.png Capricor Therapeutics, Inc. Logo /investors Equisolve Investor Relations Suite <![CDATA[Capricor Therapeutics Announces Positive Data from HOPE-3 Study of Deramiocel]]> https://www.parentprojectmd.org/capricor-therapeutics-announces-positive-data-from-hope-3-study-of-deramiocel/ Thu, 12 Mar 26 00:00:00 -0400 https://www.parentprojectmd.org/capricor-therapeutics-announces-positive-data-from-hope-3-study-of-deramiocel/ <![CDATA[FDA resumes review of Capricor’s cell therapy deramiocel ]]> https://www.thepharmaletter.com/biotech-news/fda-resumes-review-of-capricors-cell-therapy-deramiocel Wed, 11 Mar 26 00:00:00 -0400 https://www.thepharmaletter.com/biotech-news/fda-resumes-review-of-capricors-cell-therapy-deramiocel <![CDATA[Cell Therapy Deramiocel Meets Primary End Point in Phase 3 DMD Cardiomyopathy Trial]]> https://www.neurologylive.com/view/cell-therapy-deramiocel-meets-primary-end-point-phase-3-dmd-cardiomyopathy-trial Thu, 11 Dec 25 00:00:00 -0500 https://www.neurologylive.com/view/cell-therapy-deramiocel-meets-primary-end-point-phase-3-dmd-cardiomyopathy-trial <![CDATA[New trial results highlight gains in arm and heart function for DMD]]> https://musculardystrophynews.com/news/experimental-dmd-therapy-shows-promise-phase-3-trial/ Tue, 09 Dec 25 00:00:00 -0500 https://musculardystrophynews.com/news/experimental-dmd-therapy-shows-promise-phase-3-trial/ <![CDATA[Capricor says its cell therapy improved heart and muscle function in Duchenne patients]]> https://www.statnews.com/2025/12/03/capricor-cell-therapy-improves-heart-function-duchenne-patients-phase-3-trial/ Wed, 03 Dec 25 00:00:00 -0500 https://www.statnews.com/2025/12/03/capricor-cell-therapy-improves-heart-function-duchenne-patients-phase-3-trial/ <![CDATA[Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy]]> https://www.fiercebiotech.com/biotech/capricor-sets-2nd-approval-attempt-duchenne-cell-therapy-phase-3-win Wed, 03 Dec 25 00:00:00 -0500 https://www.fiercebiotech.com/biotech/capricor-sets-2nd-approval-attempt-duchenne-cell-therapy-phase-3-win <![CDATA[Capricor's cell therapy improves muscle, cardiac function in Duchenne study]]> https://firstwordpharma.com/story/6719473 Wed, 03 Dec 25 00:00:00 -0500 https://firstwordpharma.com/story/6719473 <![CDATA[Capricor cell therapy improves cardiac and upper limb function in phase 2 Duchenne muscular dystrophy victory lap]]> https://www.fiercebiotech.com/biotech/capricor-cell-therapy-improves-cardiac-and-upper-limb-function-phase-2-duchenne-muscular Fri, 11 Oct 24 00:00:00 -0400 https://www.fiercebiotech.com/biotech/capricor-cell-therapy-improves-cardiac-and-upper-limb-function-phase-2-duchenne-muscular <![CDATA[Capricor Submits BLA for Approval of Dermiocel in Treating DMD Cardiomyopathy]]> https://www.neurologylive.com/view/capricor-submit-bla-approval-dermiocel-treating-dmd-cardiomyopathy Wed, 09 Oct 24 00:00:00 -0400 https://www.neurologylive.com/view/capricor-submit-bla-approval-dermiocel-treating-dmd-cardiomyopathy <![CDATA[Watch ABC10 Interview with Dr. Craig McDonald of UC Davis discussing Capricor’s HOPE-3 trial]]> https://www.abc10.com/article/news/health/uc-davis-breakthrough-through-clinical-trial-for-muscular-dystrophy-patients/103-eda3032f-fb1e-4603-828e-7e6efdade1d5 Thu, 19 May 22 00:00:00 -0400 https://www.abc10.com/article/news/health/uc-davis-breakthrough-through-clinical-trial-for-muscular-dystrophy-patients/103-eda3032f-fb1e-4603-828e-7e6efdade1d5